Monofer, an iron deficiency drug developed by Pharmacosmos, might have faced unfair conditions on the European market for years due to possible disparaging attempts by Vifor Pharma, according to the EU Commission, whose concerns have now led to a formal antitrust investigation into the matter.
In a press release, the Commission says it appears that the Swiss firm has attempted to stifle competition for its own blockbuster drug, Ferinject, an intravenous (IV) iron deficiency treatment, by spreading false information about Monofer’s safety, which is Vifor Pharma’s ”closest – and potentially only – competitor in Europe.”
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Zealand Pharma sells shares for over USD 100m
With a 5% discount, the biotech company managed to sell 4,975,000 of its own shares in a direct issuance.
Zealand Pharma CEO: Share sale arms us for partnership negotiations
After a study success with short bowel syndrome treatment candidate, the Danish biotech company raised funding by issuing shares, preparing the company’s CEO, Adam Steensberg, to enter dialogs with a number of potential partners.
Complete company divestment is not part of Zealand Pharma's strategy
After a Nordnet analyst brought up the possibility of the Danish company being an acquisition target for foreign firms, CEO Adam Steensberg has ruled out the notion of a full sale.
Three scientists share chemistry Nobel for cancer improvement technology breakthrough
Danish national Morten Meldal and two colleagues have been awarded the prestigious award for their research into click chemistry, which is used the development of cancer drugs.
Audientes builds on Q2 momentum, maintains guidance
The hearing aid company has sold self-fitting hearing aids for over DKK 2m (USD 266,700) during the third quarter that ended in September.
CMC Writer 
Senior Project Manager 
Chief Business Officer 
KLIFO is looking for a Compliance Coordinator for our Glostrup office 
Pharmacovigliance (Associate) Director or Senior Specialist 
Lab Manager 
Quality Assurance & Regulatory Affairs Manager 
Scientist Radiochemistry 
Pharmacovigilance & Regulatory Officer 
Sales Manager Denmark 
Senior CMC Regulatory Manager